In the past decade, several promising immunotherapies have been developed, changing the treatment landscape for children with relapsed ALL. These advances in treatment offer real promise for less toxic and more effective therapy for children. In this article from Blood, the authors present several cases highlighting contemporary treatment decision-making.
According to the American Academy of Pediatrics (AAP) recommendations in “COVID-19 Interim Guidance: Return to Sports”, a positive cardiac screen or other concerning findings from a recovered COVID-19 youth patient should prompt an electrocardiogram (EKG) and potential referral to a pediatric cardiologist. The updated guidance has a focus on cardiac evaluation.
The NCI sponsors and funds the consortium, a multidisciplinary cooperative research organization devoted to the study of correlative tumor biology and new therapies for children with primary central nervous system tumors. New members are chosen through a competitive process based on several characteristics, including clinical trial infrastructure and expertise in basic and translational science.
In this article from Pediatrics, the authors explore severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and its impact on the COVID-19 transmission. The argument concludes that children, particularly school-aged children, are far less important drivers of SARS-CoV-2 transmission than adults.